# clm_65E6ADFD0D80

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: cash_and_equivalents  
value: 2,730,000,000 United States dollar  
valid_from: 2023-12-31  
valid_to: 2024-03-31  
published: 2024-02-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_BB705899FBD2  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals cash and equivalents: 2,730,000,000 United States dollar", as of 2023-12-31 (until 2024-03-31). Claim clm_65E6ADFD0D80, https://asof.is/claim/clm_65E6ADFD0D80, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2023, filed 2024-02-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm (primary, SEC EDGAR 10-K FY2023, published 2024-02-05)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,152,300,000 United States dollar | valid 2023-09-30 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_65E6ADFD0D80](/claim/clm_65E6ADFD0D80.md) | [clm_FD93D07E05CD](/claim/clm_FD93D07E05CD.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.